Our Hall of Famers list is composed of the 150 largest US-based stocks.
These stocks range from the mega-cap growth behemoths like Apple and Microsoft – with market caps in excess of $2T – to some of the new-age large-cap disruptors such as Moderna, Square, and Snap.
It has all the big names and more.
It doesn’t include ADRs or any stock not domiciled in the US. But don’t worry; we developed a separate universe for that. Click here to check it out.
The Hall of Famers is simple.
We take our list of 150 names and then apply our technical filters so the strongest stocks with the most momentum rise to the top.
Let’s dive right in and check out what these big boys are up to.
Here’s this week’s list:
*Click table to enlarge view
We filter out any laggards that are down -5% or more relative to the S&P 500 over the trailing month.
Every day, we sift through the filings to spot where the real conviction lies — cutting through the noise to highlight the most meaningful insider moves.
Here's what stood out today:
📌 Coupang $CPNG – Greenoaks Capital Partners bought $37.50 million in the ”Amazon of South Korea.”
It’s one of the biggest insider buys we’ve seen all year. Following the purchase, the firm now holds 55.2 million shares, representing about 3.66% of Coupang’s outstanding float among institutional holders.
We love our bottoms-up scans here at All Star Charts. We tend to get really creative when making new universes as we want to be sure they will deliver us the best opportunities the market has to offer.
However, when it comes to this one, it couldn't be any simpler!
With the goal of finding more bullish setups, we have decided to expand one of our favorite scans and broaden our regular coverage of the largest US stocks.
Welcome to TheJunior Hall of Famers.
This scan is composed of the next 150 largest stocks by market cap, those that come after the top 150 and are thus covered by the Hall of Famers universe. Many of these names will someday graduate and join our original Hall Of Famers list. The idea here is to catch these big trends as early on as possible.
There is no need to overcomplicate things. Market cap is a quality filter at the end of the day. It only grows if price is rising. That's good enough for us.
Off the back of last week’s crypto rally, the Crypto Industry Innovators ETF ($ETF) closed at new highs.
As markets continue their recovery, crypto remains a critical theme to watch. We’re treating Bitcoin ($IBIT) like any of the Magnificent 7 stocks, and its performance is underscoring that it’s a legitimate vehicle for a bullish tech thesis.
But it doesn’t stop with Bitcoin. A diversified basket of crypto stocks offers even more beta—more leverage to this growing trend.
This aligns perfectly with the broader speculative growth theme, where high-beta plays like these are likely to be rewarded if risk appetite returns in any meaningful way.
If the market continues its recovery, crypto stocks stand to benefit from both the tech tailwinds and the speculative growth rebound.
The question isn’t whether to consider crypto—it’s how much beta you’re ready to embrace if risk appetite comes back to life.
Every day, we sift through the filings to spot where the real conviction lies — cutting through the noise to highlight the most meaningful insider moves.
Here's what stood out today:
📌 Keros Therapeutics $KROS – Madison Avenue Partners filed an original 13G reporting an initial stake of 6.40%, jumping straight onto the cap table of this rare‑disease biotech.
📌 Tyra Biosciences $TYRA – Commodore Capital unveiled a new 5.20% stake in the precision‑oncology up‑and‑comer, another fresh biotech bet.
Here’s The Hot Corner, with data from May 14, 2025:
Click the table to enlarge it.
📌 Rep. Kelly Morrison’s Tech Dips – Rep. Morrison bought $15,000 to $50,000 slices of Broadcom $AVGO and Meta $META, adding more Capitol Hill cash to semis...
It’s been a recurring theme throughout this entire multi-year bull market—just when the bears appear to gain the upper hand, they drop the ball. Hard.
And every time they do, it’s our job as investors to strike—ruthlessly. That means getting long and leaning into strength while sentiment is still shaken.
Right now, money is flowing back into risk assets across the board. It’s starting to look like another textbook rinse-and-repeat of the many failed breakdowns we’ve seen in recent years.
Financials ($XLF) couldn’t hold their breakdown. Now they’re squeezing higher.
Communications ($XLC) tells the same story—back above support, and the path of least resistance is up, as long as we stay above that key level.
And perhaps the most important chart on our radar: Technology ($XLK) has also failed to break down relative to the broader market. That’s not just noise—it could be the early signal of tech reasserting itself as the leading sector.
We’ve seen this movie before. Failed breakdowns often lead to powerful upside moves.
In this scan, we look to identify the strongest growth stocks as they climb the market-cap ladder from small- to mid- to large- and, ultimately, to mega cap status (over $200B).
Once they graduate from small-cap to mid-cap status (over $2B), they come on our radar. Likewise, when they surpass the roughly $30B mark, they roll off our list.
But the scan doesn't just end there.
We only want to look at the strongest growth industries in the market, as that is typically where these potential 50-baggers come from.
Some of the best performers in recent decades – stocks like Priceline, Amazon, Netflix, Salesforce, and myriad others – would have been on this list at some point during their journey to becoming the market behemoths they are today.
When you look at the stocks in our table, you'll notice we're only focused on Technology and Growth industry groups such as Software, Semiconductors, Online...
Going to keep this post short today. I'm writing live from the Portfolio Accelerator event in New Orleans. Our friend Riley Rosebee is presenting as I'm typing and he is talking about stocks in companies The Jetson's would invest in.
One he brought up caught my attention because the chart looks ripe for a big pop.
As a Trader with zero to negative correlation to traditional assets, managing money on behalf of institutional investors is exactly where Jason Shapiro is supposed to be.
But if you were to ask him, he’d tell you he probably should’ve been a lawyer. And anyone else who comes to him asking about how to break into the world of full-time trading will likely get admonished with: “Go to Law School instead. Become a lawyer, then trade on the side with the money you make.”